Cresco Labs (CRLBF) Non Operating Income (2020 - 2026)

Cresco Labs (CRLBF) reported Non Operating Income of -$14.0 million for Q1 2026, up 3.72% on a YoY basis from -$13.5 million in Q1 2025, and down 20.41% quarter-over-quarter from -$11.6 million in Q4 2025.

Cresco Labs (CRLBF) Non Operating Income (2020 - 2026) Analysis & Trends

Cresco Labs has reported Non Operating Income for 7 years, with the latest figure at -$14.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Non Operating Income rose 3.72% year-over-year to -$14.0 million; the trailing twelve-month figure through Mar 2026 stood at -$66.9 million (up 43.88% YoY), and the FY2025 full-year result was -$11.2 million, up 90.54% from the prior year.
  • Non Operating Income for Q1 2026 stood at -$14.0 million, down from -$11.6 million in the prior quarter.
  • The five-year high for Non Operating Income was -$757000.0 in Q3 2022, with the low at -$73.3 million in Q2 2024.
  • Historically, Non Operating Income has averaged -$17.7 million across 5 years, with a median of -$14.3 million in 2023.
  • Annual changes were most pronounced in 2022 — Non Operating Income soared 93.61% — and 2023, when it tumbled 1410.57%.
  • Cresco Labs' Non Operating Income stood at -$13.4 million in 2022, then dropped by 6.71% to -$14.3 million in 2023, then slipped by 14.49% to -$16.4 million in 2024, then rose by 29.06% to -$11.6 million in 2025, then fell by 20.41% to -$14.0 million in 2026.
  • The last three Non Operating Income figures came in at -$14.0 million (Q1 2026), -$11.6 million (Q4 2025), and -$27.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Teva Pharmaceutical Industries 39.97 Bn 36.23 Bn 1.97 Bn -216.00 Mn
2 Zoetis 33.59 Bn 31.65 Bn 1.62 Bn 20.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -7.50 Mn
4 Neurocrine Biosciences 16.10 Bn 14.78 Bn 800.70 Mn 53.40 Mn
5 Aurora Cannabis 15.56 Bn 15.47 Bn 21.72 Mn -34,272.67
6 Elanco Animal Health 12.04 Bn 11.61 Bn 785.00 Mn -
7 Alkermes 7.36 Bn 6.84 Bn -116.06 Mn -13.65 Mn
8 Lantheus Holdings 6.74 Bn 6.24 Bn 230.92 Mn 5.71 Mn
9 Liquidia 6.27 Bn 6.04 Bn 121.79 Mn -4.72 Mn
10 Cresco Labs - - 75.45 Mn -13.97 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -13.97 Mn
Dec 31, 2025 -11.60 Mn
Sep 30, 2025 -27.93 Mn
Jun 30, 2025 -13.40 Mn
Mar 31, 2025 -14.51 Mn
Dec 31, 2024 -16.35 Mn
Sep 30, 2024 -15.02 Mn
Jun 30, 2024 -73.32 Mn
Mar 31, 2024 -13.22 Mn
Dec 31, 2023 -14.28 Mn
Sep 30, 2023 -11.44 Mn
Jun 30, 2023 -18.77 Mn
Mar 31, 2023 -14.59 Mn
Dec 31, 2022 -13.38 Mn
Sep 30, 2022 -757,000.00
Jun 30, 2022 -7.34 Mn
Mar 31, 2022 -21.14 Mn
Dec 31, 2021 -3.94 Mn
Sep 30, 2021 -11.84 Mn
Jun 30, 2021 1.24 Mn